At its best, opera is a crowning achievement in art, combining the emotive qualities of music, the dramatic interest of a narrative, and the spectacle of theatrical display. Although an opera can sometimes succeed on the basis of inspiring music alone, the greatest masterpieces weave that music into a compelling story that engages the audience. It takes a lot longer to recount a tale in song than in everyday conversation, however, and even opera aficionados have limits to their attention spans. Librettists commonly address this issue by beginning the narrative in medias res, either expecting the audience to know the historical or mythical context or employing the device of having a character succinctly inform the audience what has already occurred. This allows the compositional team to capture interest by focusing the stage action on the central conflict of the tale. Examples abound. In Il Trovatore, the captain of the guards of the nefarious Conte di Luna kicks off the songfest by recounting the convoluted events behind the Count's vendetta against Manrico; in The Flying Dutchman, Senta tells her maid, and the audience, the legend of that spectral sailor, unaware that she is about to meet him in person.
Articles in medical journals also tell a story. Like opera devotees, we orthopaedic surgeons want the storyteller to concentrate on the most compelling portion of the narrative. Patients are often expected to undergo a period of nonsurgical treatment prior to elective surgery, but the story that we really want to hear is a description of the surgical technique and its results. Like opera librettists, surgical narrators fast forward to the exciting action with a brief prologue such as this: ''The indication for hip arthroscopy in all patients was recalcitrant hip pain that was not responsive to conservative treatment for at least 6 months.'' 23(p383) The rest of the article concentrates on the patients who had surgery. Only a sentence or two may be devoted to the description of the initial nonsurgical treatment; we seldom are given enough detail to be able to reproduce the regimen for our own patients. Following this laconic statement, we rarely hear anything more about the patients for whom the nonsurgical treatment was successful and who were therefore disqualified from further consideration. We may be left wondering how many individuals fell into this category, whether they had any distinguishing characteristics that predicted their nonsurgical success, or how they fared over time. Many patients who visit our offices would like to know this information too.
Of course, studies that document the results of nonsurgical treatment do appear in the orthopaedic sports medicine literature. A trial of nonsurgical treatment seems to make the most sense in conditions like femoroacetabular impingement (FAI) and acetabular labral tears, which have been shown to exist frequently in asymptomatic individuals. 17, 18, 21 In this issue of the American Journal of Sports Medicine, Quinlan and colleagues 16 report the outcomes of 52 patients who underwent a year or more of nonsurgical treatment for documented acetabular labral tears. This regimen included an intra-articular anesthetic and steroid injection, followed by oral nonsteroidal anti-inflammatory medicine, education, activity modification, and a 3-phase physical therapy program. About 60% of the patients were women, with a mean age of 39 and Tönnis grade 2 or lower radiographic signs of degeneration. At the time of follow-up, the patients reported improved but sometimes contradictory outcomes. The percentage of patients who rated their hips as normal or nearly normal increased from 44% to 71%. Mean scores on all 4 subjective outcome instruments administered improved significantly. While 71% of patients stated they were satisfied with the results of their treatment, 48% reported no improvement in their pain, 69% noted persistent activity limitations, and 40% were still considering surgery. It seems clear that patient attitude was a major factor in the success of this program; results that satisfied some might not be acceptable to others.
Another article, published in December's AJSM, reported the results of nonsurgical treatment of FAI in a much younger population. Pennock and colleagues 15 entered a group of 76 young patients with 93 symptomatic hips into a welldefined treatment algorithm and followed them for 2 years. Averaging 15.3 years of age (range, 10-21 years), the youngsters needed to satisfy radiographic and clinical criteria for FAI to be included. All participants were begun on a physiotherapy program that focused on core stability and avoided deep flexion and internal rotation of the hip. If they improved, they were gradually returned to sports, while continuing to avoid deep flexion as much as possible. Of the 93 symptomatic hips, 65 hips were managed with this program alone. If patients did not experience enough improvement at this point, they were offered an intra-articular steroid injection. A further 11 hips received a steroid injection but did not go on to surgery. The remaining 17 hips, including 6 in which the option of an injection was waived, proceeded to arthroscopic treatment. Interestingly, participants with isolated cam impingement or combined cam and pincer impingement were more likely to undergo surgery and achieve the minimal clinically important difference on the Patient and surgeon expectations are usually a major factor in the chances of success of a nonoperative treatment program. In the Quinlan article, the authors acknowledge that the participants were both self-selected and surgeon-selected, since those with more pronounced radiographic stigmata of FAI were encouraged to undergo surgery. Pennock et al point out that the high percentage of participants who did not go on to surgery in their study may reflect the lead clinician's insistence on a trial of physiotherapy prior to considering a trip to the operating room. At the time of follow-up, 41% of their young athletes were still engaged in their original sports, 13% had switched to another activity, and 17% had given up their sport because of persistent pain. For some patients, the nonoperative regimen may have diminished their symptoms to a level that allowed them to complete a competitive high school career and then retire to a lifestyle that was less likely to elicit symptoms. These authors acknowledge that 2 years is not enough time to tell how patients who avoided surgery would fare in the long run compared with those who did have surgery.
Studies such as these not only give us insight into the efficacy of nonsurgical treatment of FAI and acetabular labral tears in different populations, but also help identify which patients are more likely to ultimately proceed to surgery. 4, 6, 25, 26 The structure of randomized trials reflects a different intent: to directly compare the efficacy of surgery and nonsurgical treatment as alternative options, rather than as complementary ones. A 2014 Cochrane review identified no such trials, 24 but they are beginning to appear in the literature. 8, 13, 22 Although a randomized trial is the best way to conduct an isolated comparison of treatment options, it is also something of an artificial construct that differs from routine clinical practice. Because the apparent efficacy of surgery for alleviating symptomatic FAI and labral tears has been demonstrated in many noncomparative studies, 1, 3, 5, 9, 11, 14 patients and surgeons usually expect the option to proceed to surgery if the nonsurgical treatment does not seem to be working. 2, 20 One such trial that compared arthroscopic and nonsurgical treatment of FAI, done in a military setting by Mansell and colleagues, 12, 13 appeared in AJSM last year and garnered considerable reader attention. 7, 19 Mansell et al 13 reported no difference between the 2 alternatives in their intention-to-treat analysis. However, because 70% of the participants originally assigned to nonsurgical treatment eventually chose to have surgery, this analysis really represents a comparison of surgery with an algorithm of initial nonsurgical treatment with the option to progress to surgery. As the authors pointed out in their discussion, ''Rehabilitation typically lies within a serial progression of treatments that occur before and leading up to surgery. It is usually not a competing treatment choice.'' 13(p1313) Although the as-treated analysis by Mansell et al detected no difference between the 2 options, the power of that comparison was limited by the relatively small number of participants who underwent nonsurgical treatment exclusively. A recently published British multicenter trial comparing arthroscopic surgery with personalized physiotherapy to treat FAI, which had more participants and a much lower rate of crossover from the nonsurgical treatment group, did demonstrate a better outcome in the surgical group that was both statistically and clinically significant. 8 Nonsurgical measures may satisfy some patients as sufficient treatment for their symptoms but merely serve as a prologue to surgery for others. Studies like those by Quinlan and Pennock and their colleagues provide a picture of the early success of nonsurgical treatments in different populations. Until we have longer follow-up, however, we won't know whether patients who eschew surgery are forgoing a treatment that might prolong the service life of their hips. 10 In surgery as in opera, knowing what occurred before the curtain rose promotes a deeper understanding of the onstage action. Authors who provide more detail on the nonsurgical methods used to treat patients prior to proceeding to surgery, and who followup patients treated both with and without surgery, will allow us to understand the long-term implications of these treatment choices.
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